UK markets open in 7 hours 2 minutes

GSK Aug 2022 43.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 12:10PM EDT. Market open.
Full screen
Previous close0.0500
Expiry date2022-08-19
Day's range0.0500 - 0.0500
Contract rangeN/A
Open interest389
  • Zacks

    GSK NDA for Myelofibrosis Candidate Gets FDA Acceptance

    GSK's NDA for momelotinib for treating myelofibrosis was based on data from key phase III studies, including the pivotal MOMENTUM study.

  • Yahoo Finance Video

    Plaintiff drops suit in first Zantac trial

    Yahoo Finance health care correspondent Anjalee Khemlani details how the first case against pharmaceutical company GSK over its Zantac derivative was voluntarily dismissed.

  • Reuters

    Plaintiff in first Zantac lawsuit set for trial drops case

    The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants. Tuesday's news came days after shares of GlaxoSmithKline Plc, Sanofi SA, Pfizer Inc and Haleon Plc were hit by mounting investor concern about thousands of lawsuits claiming the drug, which U.S. regulators pulled from the market in 2020, causes cancer. The plaintiff, Joseph Bayer, alleged he developed esophageal cancer from taking over-the-counter Zantac.